Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. MET Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

MetLife (MET)

Market Price (9/18/2025): $78.8 | Market Cap: $52.9 Bil
Sector: Financials | Industry: Life & Health Insurance

MetLife (MET)

Market Price (9/18/2025): $78.8
Market Cap: $52.9 Bil
Sector: Financials
Industry: Life & Health Insurance

Investment Highlights

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 2.9%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.5%, FCF Yield is 29%		 Weak multi-year price returns
2Y Excs Rtn is -17%, 3Y Excs Rtn is -35%		 Weak revenue growth
Rev Chg QQuarterly Revenue Change % is -1.8%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -176%		  
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 21%, CFO LTM is 15 Bil, FCF LTM is 15 Bil		  
3 Low stock price volatility
Vol 12M is 29%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 2.9%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.5%, FCF Yield is 29%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -176%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 21%, CFO LTM is 15 Bil, FCF LTM is 15 Bil
3 Low stock price volatility
Vol 12M is 29%
4 Weak multi-year price returns
2Y Excs Rtn is -17%, 3Y Excs Rtn is -35%
5 Weak revenue growth
Rev Chg QQuarterly Revenue Change % is -1.8%

Market Valuation

 9/18/252024202320222021
Share Price CYE$78.80$80.15$62.78$66.42$55.71
Market Cap CYE ($ Bil)52.955.546.452.146.7
Total Debt ($ Bil)19.918.718.818.017.4
Total Cash ($ Bil)22.220.120.620.220.0
Enterprise Value ($ Bil)50.674.265.270.164.1
Valuation Ratios     
P/S TTM0.70.80.80.90.8
P/EBIT TTM7.88.715.68.05.7
P/E TTM12.313.131.811.07.9
Sector Ratios     
P/S TTM (Sector)3.23.12.82.83.4
P/EBIT TTM (Sector)6.86.87.17.17.0
P/E TTM (Sector)12.811.610.29.410.0
 9/18/2520242023
Share Price CYE$78.80$80.15$62.78
Market Cap CYE ($ Bil)52.955.546.4
Total Debt ($ Bil)19.918.718.8
Total Cash ($ Bil)22.220.120.6
Enterprise Value ($ Bil)50.674.265.2
Valuation Ratios   
P/S TTM0.70.80.8
P/EBIT TTM7.88.715.6
P/E TTM12.313.131.8
Sector Ratios   
P/S TTM (Sector)3.23.12.8
P/EBIT TTM (Sector)6.86.87.1
P/E TTM (Sector)12.811.610.2

Market Cap Chart

Business Description

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
MET Return-3%37%19%-5%28%-2%93%
Peers Return-9%33%13%8%27%8%101%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: TRV, ALL, AIG, PRU, HIG. See MET Returns vs. Peers.
[3] 2025 data is for the year up to 9/17/2025 (YTD)

Interactive Breakdown

MetLife Interactive Breakdown Analysis

Better Bets than MetLife (MET)

 METBetter Performance than MET
MetricValueIndustry (Life & Health Insurance)
Rev Chg LTM5.9%MFC (10.0%), PRI (7.8%), JXN (26.8%), BHF (61.5%), TRUP (13.1%)
Rev Chg 3Y Avg6.0%JXN (169.2%), BHF (15.2%), TRUP (19.4%), TIPT (17.0%), AMBC (118.6%)
CFO/Rev LTM21.1%MFC (60.3%), PFG (28.9%), GL (24.1%), PRI (26.5%), JXN (103.0%)
FCF/Rev LTM21.1%MFC (60.3%), PFG (28.4%), GL (22.9%), PRI (25.6%), JXN (103.0%)
Total Yield11.0%MFC (17.5%), PRU (11.5%), UNM (14.0%), AXS (14.0%), BHF (25.2%)
 METBetter Performance than MET
MetricValueAll Other Sectors
Rev Chg LTM5.9%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg6.0%NVDA (92.0%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%), META (13.0%)
CFO/Rev LTM21.1%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), META (56.4%)
FCF/Rev LTM21.1%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), META (30.7%), AVGO (41.6%)
Total Yield11.0%BABA (37.9%), TM (2077.1%), MRK (12.0%), VZ (15.8%), PFE (13.2%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Day 5 of Gains Streak for MetLife Stock with 5.4% Return (vs. 1.7% YTD) [8/22/2025]Notification 
2MET Dip Buy Analysis  
3MetLife Total Shareholder Return (TSR): 30.3% in 2024 and 15.8% 3-yr compounded annual returns (below peer average)  
4MetLife (MET) Operating Cash Flow ComparisonFinancials 
5MetLife (MET) Net Income ComparisonFinancials 
6MetLife vs. S&P500 CorrelationCorrelation 
7MetLife Price VolatilityVolatility 
8null  
9Fundamental Metrics: ...  
10MetLife vs. Large Cap Stocks: Which Is A Better Investment?Investment Theme Comparisons 
11ARTICLES  
12MET Stock Up 5.4% after 5-Day Win Streak August 22nd, 2025
13How To Trade MetLife Stock Ahead Of Q2 Earnings? August 1st, 2025
14What To Expect From MetLife Stock In 2025? January 2nd, 2025
15MetLife Stock Is Trailing S&P500 In YTD Returns, What To Expect? August 9th, 2024
16Dropping 5% Since The Start Of 2023, Can MetLife Stock Rebound? January 22nd, 2024

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11931.7%11931.7%
2GIBOGIBO10714.0% 
3LNZALanzaTech Global8455.2%-86.3%
4GTIGraphjet Technology3998.4%-93.1%
5GWAVGreenwave Technology Solutions3582.8%-91.4%
6QMMMQMMM3409.6%8153.1%
7ECDAECD Automotive Design2715.2%307.9%
8OESXOrion Energy Systems1373.7%14.2%
9OPOceanPal1266.5%-95.6%
10BCTXBriaCell Therapeutics1032.4%-89.8%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-94.5%-96.0%
2STFSStar Fashion Culture-92.3%-97.9%
3ELPWElong Power-91.1%-76.9%
4NXTTNext Technology-90.1%-95.4%
5EPIXESSA Pharma-89.4%-8.9%
6NAKAKindly MD-88.1% 
7BINIBollinger Innovations-87.6%-100.0%
8JEM707 Cayman-87.4%-98.2%
9YAASYouxin Technology-83.3%-98.4%
10NEONNeonode-82.5%-51.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for MetLife

Financials

METTRVALLAIGPRUHIGMedian
NameMetLife Traveler.Allstate American.Prudenti.Hartford. 
Mkt Price78.68275.03197.2576.80103.01130.65116.83
Mkt Cap52.862.152.244.036.537.148.1
Rev LTM72,07847,84366,21427,74360,62027,25954,232
Op Inc LTM-------
FCF LTM15,2299,6338,5383,1597755,6907,114
FCF 3Y Avg13,7938,1016,4174,7965,8884,8166,152
CFO LTM15,2299,6338,7433,1597755,8287,286
CFO 3Y Avg13,7938,1016,6714,7965,8885,0036,279

Growth & Margins

METTRVALLAIGPRUHIGMedian
NameMetLife Traveler.Allstate American.Prudenti.Hartford. 
Rev Chg LTM5.9%8.5%9.8%2.2%-0.2%7.8%6.8%
Rev Chg 3Y Avg6.0%10.2%9.7%-8.5%-2.8%8.1%7.1%
Rev Chg Q-1.8%7.4%5.7%7.2%-42.5%7.8%6.4%
QoQ Delta Rev Chg LTM-0.4%1.8%1.4%1.7%-14.2%1.9%1.5%
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM21.1%20.1%13.2%11.4%1.3%21.4%16.7%
CFO/Rev 3Y Avg19.7%18.5%10.9%19.7%9.7%19.6%19.0%
FCF/Rev LTM21.1%20.1%12.9%11.4%1.3%20.9%16.5%
FCF/Rev 3Y Avg19.7%18.5%10.5%19.7%9.7%18.9%18.7%

Valuation

METTRVALLAIGPRUHIGMedian
NameMetLife Traveler.Allstate American.Prudenti.Hartford. 
Mkt Cap52.862.152.244.036.537.148.1
P/S0.71.30.81.60.61.41.0
P/EBIT7.89.06.88.6-8.78.6
P/E12.311.89.013.815.911.412.1
P/CFO3.56.46.013.947.16.46.4
Total Yield11.0%9.2%13.1%9.5%11.5%10.3%10.7%
Dividend Yield2.9%0.8%1.9%2.2%5.2%1.5%2.1%
FCF Yield 3Y Avg28.1%16.6%15.5%10.3%15.6%16.3%16.0%
D/E0.40.10.20.20.60.10.2
Net D/E-1.8-1.4-0.0-0.6-1.3-0.5-1.0

Returns

METTRVALLAIGPRUHIGMedian
NameMetLife Traveler.Allstate American.Prudenti.Hartford. 
1M Rtn1.2%4.2%-4.3%-3.9%-3.4%1.1%-1.2%
3M Rtn0.9%4.2%1.3%-8.3%0.2%5.0%1.1%
6M Rtn-3.8%6.1%-2.8%-7.2%-4.5%10.0%-3.3%
12M Rtn3.4%15.7%5.7%6.6%-9.0%13.5%6.1%
3Y Rtn32.6%79.5%63.8%53.0%29.8%112.2%58.4%
1M Excs Rtn-1.1%1.9%-6.6%-6.2%-5.7%-1.3%-3.5%
3M Excs Rtn-8.5%-5.9%-10.3%-18.6%-9.4%-5.8%-8.9%
6M Excs Rtn-19.7%-11.1%-20.6%-25.1%-21.3%-6.8%-20.1%
12M Excs Rtn-11.1%0.2%-10.5%-9.4%-24.4%-2.2%-10.0%
3Y Excs Rtn-34.6%15.7%6.2%-14.5%-40.9%43.9%-4.2%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/7/20255/1/20252/21/202511/1/20248/1/20245/2/20242/16/202411/2/20238/4/20235/4/20232/23/202311/3/2022
Key Financials Quarterly            
Total Revenue17,16018,28418,37618,25817,48215,90219,02815,65916,38015,45616,12722,384
Net Income7299451,2711,342946867607489402801,5781,162
EPS1.041.291.781.821.281.110.770.560.480.021.691.38
Key Financials TTM            
Total Revenue TTM72,07872,40070,01870,67068,07166,96966,52363,62270,34769,03167,82168,150
Net Income TTM4,2874,5044,4263,7622,9092,3651,5782,5493,2223,7305,2845,212
Growth Rates Quarterly            
Total Revenue Growth-1.8%15.0%-3.4%16.6%6.7%2.9%18.0%-30.0%8.7%8.5%-2.0%47.0%
Net Income Growth-22.9%9.0%109.4%174.4%135.3%983.8%-61.5%-57.9%-55.8%-95.1%4.8%-26.6%
Margins Quarterly            
Net Income Margin4.2%5.2%6.9%7.4%5.4%5.5%3.2%3.1%2.5%0.5%9.8%5.2%
Cash & Debt            
Total Cash112,685109,125100,570320,153302,326303,133308,096292,391306,195306,494301,910298,231
Total Debt19,90619,22918,71518,84518,36219,26118,82818,79617,89917,94917,98017,861
Net Debt / (Cash)-92,779-89,896-81,855-301,308-283,964-283,872-289,268-273,595-288,296-288,545-283,930-280,370
Cash Flows Quarterly            
FCF from Operations2,1874,2624,6114,1693,4902,3285,1823,4753,0382,0262,3014,310
Cash Flows TTM            
FCF from Operations TTM15,22916,53214,59815,16914,47514,02313,72110,84011,67513,03013,04415,834
Returns to Shareholders Quarterly            
Dividends382374378383389377386392399389393400
Share Repurchases5101,4114067748551,172859792672780596674
Return on Invested Capital (ROIC) Quarterly            
ROIC------------
Return on Invested Capital (ROIC) TTM            
ROIC TTM------------

Price Behavior

MET Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta1.321.231.111.191.110.95
Up Beta1.321.671.561.041.070.92
Down Beta0.850.520.881.431.371.15
Up Capture176%99%82%106%90%62%
Bmk +ve Days10223571142415
Stock +ve Days15263972140409
Down Capture102%153%121%122%101%98%
Bmk -ve Days11192754106334
Stock -ve Days6162454107338

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity9,083,033
Short Interest: % Change Since 81520254.5%
Average Daily Volume2,639,618
Days-to-Cover Short Interest3.44
Basic Shares Quantity670,800,000
Short % of Basic Shares1.4%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/6/2025-2.8%1.9%4.7%
4/30/20250.5%2.6%5.0%
2/5/2025-1.6%-2.7%-3.2%
10/30/2024-5.7%0.8%6.8%
7/31/2024-1.4%-9.8%0.7%
5/1/2024-2.3%0.5%1.5%
1/31/2024-5.7%-2.6%1.4%
11/1/20230.1%-0.2%7.2%
...
SUMMARY STATS   
# Positive111417
# Negative13107
Median Positive2.1%2.5%4.7%
Median Negative-2.1%-2.6%-8.3%
Max Positive6.1%16.7%25.3%
Max Negative-7.8%-10.9%-24.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025807202510-Q 6/30/2025
3312025501202510-Q 3/31/2025
12312024221202510-K 12/31/2024
93020241101202410-Q 9/30/2024
6302024801202410-Q 6/30/2024
3312024502202410-Q 3/31/2024
12312023216202410-K 12/31/2023
93020231102202310-Q 9/30/2023
6302023804202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022223202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022804202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021218202210-K 12/31/2021
93020211109202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0PAPPAS BILLEVP, Global Tech. & Ops.5132025Sell80.4926,0002,092,6835,372,078Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.